GENERIC NAME OF THE MEDICINAL PRODUCT:
B. Telmisartan + Metoprolol Succinate (ER) Tablets (40mg+25mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film coated bilayered tablet contains:
Telmisartan IP…………………………………….40mg
Metoprolol succinate IP……………………..47.5mg
Equivalent to Metoprolol tartrate………50mg
(As extended release form)
Colour: Tartrazine
B) Telmisartan + Metoprolol Succinate (ER) Tablets (40mg+25mg)
Each film coated bilayered tablet contains:
Telmisartan IP…………………………………….40mg
Metoprolol succinate IP……………………..23.75mg
Equivalent to Metoprolol tartrate………25mg
(As extended release form)
Colour: Tartrazine & Titanium dioxide IP
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
Reducing salt intake and taking medicines as per doctor’s advice can reduce blood pressure.
WARNING: WHEN PREGNANCY IS DETECTED, TELMISARTAN SHOULD BE DISCONTINUED AS SOON AS POSSIBLE AS IT CAN CAUSE INJURY AND EVEN DEATH TO THE DEVELOPING FETUS WHEN USED DURING SECOND AND THIRD TRIMESTERS OF PREGNANCY.
SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
STORAGE & DOSAGE:
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician
Telmisartan + Metoprolol Succinate (ER) Tablets (40mg+25mg) Technical Specification:
| Product Name: | Telmisartan + Metoprolol Succinate (ER) Tablets |
| Brand Name: | Generic |
| Strength: | (40mg+50mg), (40mg+25mg) |
| Dosage Form: | Tablets (Film coated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10 Blister strips of 10 Tablets Each |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antihypertensive |
| Indication: | Telmisartan + Metoprolol belongs to the class antihypertensive agents used to treat hypertension (high blood pressure). It may also be used to lower the risk of heart attack and stroke in future. |
| Storage: | Store at temperature not exceeding 30℃. Store in cool, dry & dark place. Protect from Light & moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Telmisartan + Metoprolol Succinate (ER) Tablets (40mg+25mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Telmisartan + Metoprolol Succinate (ER) Tablets (40mg+25mg)
Each film coated Bilayered tablet contains:
Telmisartan IP…………………………………….40mg
Metoprolol succinate IP……………………..23.75mg
Equivalent to Metoprolol tartrate………25mg
(As extended release form)
Colour: Tartrazine & Titanium dioxide IP
THERAPEUTIC INDICATIONS:
Telmisartan + Metoprolol belongs to the class antihypertensive agents used to treat hypertension (high blood pressure). It may also be used to lower the risk of heart attack and stroke in future.
CAUTION & SCHEDULE:
CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed.}
Reducing salt intake and taking medicines as per doctor’s advice can reduce blood pressure.
WARNING: When pregnancy is detected, Telmisartan should be discontinued as soon as possible as it can cause injury and even death to the developing fetus when used during second and third trimesters of pregnancy.
SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
STORAGE & DOSAGE:
Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician.
Introduction: Understanding Telmisartan + Metoprolol Succinate (ER) Tablets (40mg+25mg)
Telmisartan + Metoprolol Succinate (ER) Tablets (40mg+25mg) are a combination medication used primarily for the treatment of hypertension (high blood pressure) and to reduce the risk of heart attacks and strokes.
This fixed-dose combination includes:
-
Telmisartan (40mg) – An angiotensin II receptor blocker (ARB) that relaxes blood vessels and lowers blood pressure.
-
Metoprolol Succinate (25mg, extended-release) – A beta-blocker that reduces heart rate and workload, improving overall cardiac efficiency.
Together, they provide dual protection by controlling blood pressure, improving heart function, and preventing cardiovascular complications.
Taj Pharma, the well-known Telmisartan + Metoprolol Succinate (ER) Tablets (40mg+25mg) Manufacturer in India, ensures high-quality, efficacy, and purity in every batch, meeting the stringent global regulatory standards for pharmaceutical exports.
Global Demand for Telmisartan + Metoprolol Succinate (ER) Tablets
The global antihypertensive drug market is growing rapidly due to rising cases of cardiovascular diseases, obesity, and diabetes. Millions of patients depend on combination therapies like Telmisartan + Metoprolol Succinate (ER) Tablets (40mg+25mg) for effective long-term blood pressure management.
India, recognized as the pharmacy of the world, supplies affordable, WHO-GMP-certified generic medicines to more than 200 countries. Among Indian manufacturers, Taj Pharma Ltd (Vapi, Gujarat) has emerged as a trusted partner for importers, hospitals, and distributors worldwide.
Composition and Mechanism of Action
Each film-coated tablet contains:
-
Telmisartan 40mg
-
Metoprolol Succinate (ER) 25mg
Mechanism:
-
Telmisartan blocks angiotensin II receptors, preventing blood vessel constriction and lowering blood pressure.
-
Metoprolol Succinate, a cardioselective beta-blocker, slows down the heart rate, decreases myocardial oxygen demand, and enhances cardiac output.
The combination ensures round-the-clock blood pressure control, particularly beneficial for patients with resistant hypertension or cardiovascular risk.
Therapeutic Uses
-
Treatment of Hypertension (High Blood Pressure)
-
Prevention of Heart Attacks and Strokes
-
Management of Stable Angina and Cardiomyopathy
-
Improves heart function in hypertensive diabetic patients
Common Side Effects
Most side effects are mild and resolve as the body adjusts to the medication.
Commonly reported effects include:
-
Headache
-
Weakness or fatigue
-
Dizziness
-
Cold extremities
-
Slow heart rate
-
Elevated potassium levels
-
Numbness in limbs
-
Decreased blood pressure
Tip: Patients should avoid abrupt discontinuation and rise slowly from sitting or lying positions to prevent dizziness.
For Importers, Exporters, and Global Buyers
Taj Pharma provides comprehensive pharmaceutical export support, from regulatory documentation to customized packaging, ensuring seamless trade for importers and distributors worldwide.
1. Regulatory Documentation Provided
-
WHO-GMP Certificate
-
COPP (Certificate of Pharmaceutical Product)
-
CTD/ACTD Dossier (Modules 1–5)
-
Free Sale Certificate
-
Stability Studies (Zone IVb)
-
Certificate of Analysis (COA) & Method of Analysis (MOA)
-
Manufacturing License and Batch Manufacturing Record
2. Custom Packaging & Private Labeling
Taj Pharma supports custom packaging solutions to suit international buyer needs:
-
Blister, Alu-Alu, or bottle packs
-
Custom artwork and branding
-
Multilingual labeling and barcoding
-
Export-standard secondary packaging
3. Shelf Life, Storage, and Dosage Form
-
Dosage Form: Film-coated extended-release tablets
-
Packaging: 10×10 or 3×10 tablets per carton
-
Shelf Life: 24–36 months
-
Storage: Store below 25°C, away from moisture and light
4. Export Certifications
Taj Pharma’s export-ready products come with:
-
WHO-GMP & ISO 9001:2015 Certification
-
EU-GMP & COPP approvals
-
Dossiers in CTD/ACTD formats
-
Registration-ready documentation for global tenders
5. Target Export Markets
Taj Pharma exports to 40+ countries, including:
-
Africa: Kenya, Ghana, Nigeria, Uganda
-
Asia: Vietnam, Myanmar, Philippines, Sri Lanka
-
Middle East: Iraq, Yemen, UAE, Oman
-
CIS Countries: Uzbekistan, Kazakhstan, Tajikistan
-
Latin America: Peru, Chile, Bolivia, Ecuador
Why Taj Pharma is the Most Trusted Manufacturer and Supplier
1. State-of-the-Art WHO-GMP Manufacturing Facilities
Located in Vapi, Gujarat, Taj Pharma’s WHO-GMP-certified plant features automated production lines, modern analytical labs, and advanced cleanroom technology, ensuring international quality compliance.
2. Affordable Pricing and Superior Quality
Taj Pharma guarantees affordable and globally competitive pricing without compromising on quality. This balance helps importers maximize margins while offering patients cost-effective hypertension therapy.
3. Global Regulatory Compliance
Each batch undergoes multiple quality checks following WHO-GMP, EU-GMP, and ISO 9001:2015 guidelines. Taj Pharma’s adherence to ICH stability and pharmacopeial standards (IP/BP/USP) makes it a reliable export partner.
4. Strong Supply Chain Network
With efficient logistics and global partnerships, Taj Pharma ensures timely deliveries, temperature-controlled shipments, and custom clearance assistance.
5. Export Leadership:
USA, UK, South Africa, Kenya, Nigeria, Ghana, Vietnam, Myanmar, Philippines, Bangladesh, Sri Lanka, Iraq, Yemen, Uzbekistan, Kazakhstan, Georgia, Peru, Bolivia, Ukraine, Cambodia
Technical Product Specifications
| Product Name | Telmisartan + Metoprolol Succinate (ER) Tablets (40mg+25mg) |
|---|---|
| Manufacturer | Taj Pharma India Ltd |
| Form | Extended-Release Oral Tablet |
| Composition | Telmisartan 40mg + Metoprolol Succinate (ER) 25mg |
| Indication | Hypertension, Heart Disease Prevention |
| Packaging | 10×10 / 3×10 Blister or Alu-Alu Packs |
| Shelf Life | 24–36 Months |
| Storage | Below 25°C, Dry & Dark Place |
| Certifications | WHO-GMP, ISO 9001:2015, EU-GMP, COPP |
| Market | Domestic & International |
| Brand Name (if any) | Customizable for export clients |
Therapeutic Benefits of Telmisartan + Metoprolol Succinate (ER) Tablets (40mg+25mg)
-
Dual-action blood pressure control (vasodilation + reduced heart workload)
-
Once-daily dosing ensures 24-hour efficacy
-
Improved heart rate stability
-
Lowers risk of heart failure, stroke, and kidney damage
-
Enhanced patient compliance and safety profile
Why Choose Taj Pharma India for Global Supply?
Taj Pharma has built a reputation as one of the most reliable exporters and suppliers of cardiovascular and antihypertensive medicines from India. The company provides high-quality, cost-effective generic formulations that meet global healthcare standards.
Key Differentiators:
✅ Over 25 years of manufacturing excellence
✅ Comprehensive documentation and technical support
✅ Custom branding for distributors and franchise partners
✅ Strong export network across 5 continents
✅ Trusted by hospitals, government tenders, and PCD franchise companies
Call to Action:
If you are a pharmaceutical distributor, importer, or PCD franchise owner, connect with Taj Pharma—India’s most trusted Telmisartan + Metoprolol Succinate (ER) Tablets (40mg+25mg) Manufacturer and Exporter.
📩 Contact Taj Pharma Today
Taj Pharma India Ltd
Plot No. 513, GIDC Industrial Estate, Vapi, Gujarat, India
🌐 Website: www.tajpharma.in
📧 Email: info@tajpharma.com
📞 Phone: +91 84484 44095 (Gen. Enq. 01)
Collaborate with Taj Pharma to ensure reliable supply, regulatory compliance, and global-quality pharmaceutical solutions.
Top 20 FAQs
1. What is Telmisartan + Metoprolol Succinate (ER) used for?
It treats high blood pressure and reduces cardiovascular risk, improving heart health.
2. Who manufactures it in India?
Taj Pharma Ltd, based in Vapi, Gujarat, India.
3. Is the product WHO-GMP certified?
Yes, manufactured in a WHO-GMP, ISO, and EU-GMP compliant facility.
4. What are the available packaging options?
10×10 and 3×10 blister or Alu-Alu packs, customizable for export.
5. What is the shelf life?
24–36 months under standard storage conditions.
6. Can importers get product dossiers?
Yes, CTD/ACTD dossiers are provided for registration.
7. What are the side effects?
Common effects include dizziness, fatigue, and low heart rate.
8. Is private labeling available?
Yes, Taj Pharma provides custom branding and packaging.
9. Which countries import this medicine?
Over 40 countries across Asia, Africa, Latin America, and the Middle East.
10. What is the dosage form?
Extended-release (ER) oral tablets.
11. Can it be combined with other antihypertensives?
Only under medical supervision.
12. What is the advantage of ER formulation?
Ensures sustained drug release for 24-hour control.
13. Are stability studies available?
Yes, stability data for Zone IVb is provided.
14. Can I get WHO-GMP and COPP certificates?
Yes, available on request for export registration.
15. What is the lead time for exports?
Typically 30–45 days after order confirmation.
16. Is this product cost-effective?
Yes, Taj Pharma offers globally competitive pricing.
17. What’s the mode of shipment?
By air or sea, depending on buyer preference.
18. Are Taj Pharma products registered internationally?
Yes, in multiple regulated and semi-regulated markets.
19. Can hospitals directly procure from Taj Pharma?
Yes, bulk and institutional supplies are accepted.
20. Why choose Taj Pharma?
Because Taj Pharma stands for trust, global quality, and on-time delivery.
Taj Pharma has established itself as a pioneer in cardiovascular and antihypertensive formulation manufacturing. As the leading Telmisartan + Metoprolol Succinate (ER) Tablets (40mg+25mg) Manufacturer, Supplier, and Exporter in India, Taj Pharma continues to deliver excellence through innovation, compliance, and commitment to quality.






